peptide mimetic inhibitors (Provid/Suntory)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namepeptide mimetic inhibitors (Provid/Suntory)
Drug Alias NameMHC-DR2 inhibitors (Provid/Suntory)MHC-DR2 inhibitors (Provid)
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProvid Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuntory PharmaceuticalProvid Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A